Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research

ALBANY, New York, March 13, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the global peptide therapeutics market was valued at USD 14.1 billion in 2011 and is estimated to reach a market worth USD 25.4 billion in 2018 at a CAGR of 8.7% from 2012 to 2018.

Browse the full report at http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

The growth of the market is driven by factors such as rising incidences of cardiovascular diseases, metabolic diseases and technological enhancement in peptide synthesis. The Asian region offers future growth prospects to the peptide industry owing to vast unmet medical needs and rising disposable income of patients.

Amongst the application market, the cancer peptide segment accounted for the largest share of approximately 21% and is expected to grow at a healthy CAGR during the forecast period. The neuropeptides application segment is anticipated to grow at a CAGR of 9.4% from 2012 to 2018 due to the rise in number of neurological disorders such as Alzheimer's and Parkinson's disease.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/radiopharmaceuticals-market.html

http://www.transparencymarketresearch.com/healthcare-cloud-computing.html

http://www.transparencymarketresearch.com/hcro-market.html

http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html

http://www.transparencymarketresearch.com/bioinformatics-market.html

The parenteral route of administration of peptides accounted for the largest share of around 86% in year 2011, in terms of routes of administration; however other routes of administration like oral, pulmonary, nasal and intradermal are also being tested and are estimated to experience healthy growth rate during the forecast period.

Technological enhancement with introduction of hybrid technology along with solid phase peptide syntheses (SPPS) is expected to enhance the growth of peptide therapeutics. The hybrid technology segment which provides the best of both solid and liquid syntheses is now being adopted by major players and hence this market is expected to see the highest growth of 12.1% from 2012 to 2018.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/cinv-market.html

http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-Ingredients-market.html

http://www.transparencymarketresearch.com/global-neuromodulation-devices-market.html

http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html

http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

The North American peptide therapeutics market held majority of the market share of approximately 40% in 2011 owing to its developed economy. However, due to rise in cost containment and budgetary cuts in North America, emerging countries such as India, China and other Latin American countries is expected to see a healthy growth in the study period.

Some of the key market players are Eli Lilly, Roche, Amylin, Novo-Nordisk, Ipsen and others. The contract manufacturing organization (CMO) industry includes major players such as Bachem, Polypeptide Group, Lonza, Peptisyntha and others.

• Peptide Therapeutics Market, by Applications

  Cancer

  Metabolic

  Cardiovascular

  Dermatology

  Anti-Infection

  Neurology

  Gastro Intestinal

  Renal

  Respiratory

  Pain

  Others

• Peptide Therapeutics Market, by Route of Administration

  Parenteral

  Oral

  Pulmonary

  Mucosal

  Others

• Peptide Therapeutics Market, by Types

  Innovative

  Generics

• Peptide Therapeutics Market, by API Peptide

  In-House

  CMO (Contract Manufacturing Organization)

• Peptide Therapeutics by technology

  Liquid Phase Peptide Synthesis (LPPS)

  Solid Phase Peptide Synthesis (SPPS)

  Hybrid

• Peptide Therapeutics Market, by Geography

  North America

  Europe

  Asia

  RoW

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Upcoming Reports in Pharmaceutical Market

Metabolomics Market

Medical Tourism Market

Monoclonal Antibodies Market

Cell Based Assays Market

Nutraceuticals Market

Drug Discovery Technologies Market

Sample Preparation In Genomics

Antibody Drugs Market

Osteoporosis Market

Treatments for Neurodegenerative Disorders

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Visit: http://de.transparencymarketresearch.com/
Visit: http://www.transparencymarketresearch.com/